Hypotrichosis Clinical Trial
Official title:
Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01448525 -
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
|
Phase 4 | |
| Completed |
NCT00958035 -
Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
|
Phase 4 | |
| Completed |
NCT01891487 -
Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
|
Phase 4 | |
| Recruiting |
NCT05790941 -
Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation
|
Early Phase 1 | |
| Recruiting |
NCT05723198 -
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
|
Phase 3 | |
| Completed |
NCT01200251 -
Study of Bimatoprost Gel on Eyelash Growth
|
Phase 3 | |
| Completed |
NCT00907426 -
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
|
Phase 3 |